Cipla launches ‘Covi-G’ for COVID-19 rapid antibody detection
Cipla signed a licensing agreement with MultiG for COVID-19 rapid antibody test kit Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) and hereafter referred to as “Cipla”) today announced that it signed a licensing agreement with a Belgium-based firm, Multi G for the distribution of their COVID-19 Rapid Antibody test kit, across most Emerging markets and Europe. […]